Continuous Improvement and the Expansion of Quality ... - NCQA

Recommendations

Info

MEASURE T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • A P P E N D I C E S HEdIs EffECtIvEnEss of CarE MEasurEs CoMMErCIal HMo statIstICs—2010 90TH PERCENTIlE 10TH PERCENTIlE DIffERENCE Childhood Immunization Status—Hepatitis A 54.6 20.0 34.6 Childhood Immunization Status—Rotavirus 78.8 47.0 31.8 Childhood Immunization Status—Influenza 70.1 41.8 28.2 Childhood Immunization Status—Combination 10 (DTaP, IPV, MMR, Hib, Hepatitis A, Hepatitis b, VzV, PCV, Rotavirus and Influenza) 30.9 8.3 22.6 Immunizations for Adolescents—Meningococcal 77.7 35.9 41.7 Immunizations for Adolescents—Tdap/Td 91.9 46.1 45.8 Immunizations for Adolescents—Combination 1 (Meningococcal, Tdap/Td) 75.2 30.6 44.6 follow-Up Care for Children Prescribed ADHD Medication—Initiation 49.0 30.7 18.4 follow-Up Care for Children Prescribed ADHD Medication—Continuation 55.6 31.3 24.3 Weight Assessment and Counseling for Nutrition and Physical Activity in Children and Adolescents—bMI Percentile (overall) Weight Assessment and Counseling for Nutrition and Physical Activity in Children and Adolescents—Counseling for Nutrition (overall) Weight Assessment and Counseling for Nutrition and Physical Activity in Children and Adolescents—Counseling for Physical Activity (overall) 75.9 0.2 75.7 74.1 0.2 73.9 70.1 0.0 70.1 Well-Child Visits: Ages 0–15 Months—No Well-Child Visits 3.6 0.0 3.6 Well-Child Visits: Ages 0–15 Months—one Well-Child Visit 2.0 0.0 2.0 Well-Child Visits: Ages 0–15 Months—Two Well-Child Visits 2.5 0.0 2.5 Well-Child Visits: Ages 0–15 Months—Three Well-Child Visits 3.9 0.4 3.5 Well-Child Visits: Ages 0–15 Months—four Well-Child Visits 8.3 1.9 6.4 Well-Child Visits: Ages 0–15 Months—five Well-Child Visits 21.7 5.9 15.9 Well-Child Visits: Ages 0–15 Months—Six or More Well-Child Visits 89.6 61.1 28.6 Well-Child Visits: Ages 3–6 years—one or More Well-Child Visits 84.5 56.9 27.7 Adolescent Well-Care Visits—At least one Comprehensive Well-Care Visit 60.2 28.5 31.7 Children and Adolescents' Access to Primary Care Practitioners— Children 12–24 Months Children and Adolescents’ Access to Primary Care Practitioners— Children 25 Months–6 years Children and Adolescents’ Access to Primary Care Practitioners— Children 7–11 years Children and Adolescents’ Access to Primary Care Practitioners— Adolescents 12–19 years *Lower rates signify better performance. 173 99.4 95.4 4.0 95.7 86.2 9.4 96.7 86.8 9.9 95.1 83.5 11.6
174 APPENDIx 14b: VARIATIoN IN PlAN PERfoRMANCE: THE 90TH PERCENTIlE VS. THE 10TH PERCENTIlE: CoMMERCIAl PPoS MEASURE safety and Potential Waste N AT I o N A l C o M M I T T E E f o R Q U A l I T y A S S U R A N C E HEdIs EffECtIvEnEss of CarE MEasurEs CoMMErCIal PPo statIstICs—2010 90TH PERCENTIlE 10TH PERCENTIlE DIffERENCE Imaging Studies for low back Pain 80.6 65.4 15.2 Avoidance of Antibiotic Treatment in Adults With Acute bronchitis 27.1 15.9 11.2 Ambulatory Care—ED Visits per 1,000 Member Months 208.8 133.3 75.6 Wellness and Prevention Adult bMI Assessment 47.3 0.8 46.5 Medical Assistance With Smoking and Tobacco Use Cessation— Advising Smokers and Tobacco Users to Quit 79.8 65.3 14.5 Medical Assistance With Smoking and Tobacco Use Cessation— Discussing Cessation Strategies Medical Assistance With Smoking and Tobacco Use Cessation— Discussing Cessation Medications 47.0 32.6 14.4 55.6 38.8 16.7 flu Shots for Adults 57.9 45.3 12.6 Prenatal and Postpartum Care—Timeliness of Prenatal Care 96.0 41.6 54.4 Prenatal and Postpartum Care—Postpartum Visit between 21 and 56 Days After Delivery 87.1 36.2 50.9 breast Cancer Screening 72.5 62.2 10.3 Cervical Cancer Screening 79.0 69.2 9.8 Colorectal Cancer Screening 55.3 41.1 14.2 Chlamydia Screening in Women—16–20 years 48.2 29.5 18.7 Chlamydia Screening in Women—21–24 years 55.2 30.6 24.6 Chlamydia Screening in Women—Total Rate 51.0 29.9 21.0 Chronic disease Management Persistence of beta-blocker Treatment After a Heart Attack 79.9 62.3 17.6 Comprehensive Diabetes Care—blood Pressure Control (
Page 1 and 2:
Continuous Improvement and the Expa
Page 3 and 4:
2 This Report and the data containe
Page 5 and 6:
4 N AT I o N A l C o M M I T T E E
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
top 10 and bottom 10 states “loca
Page 15 and 16:
Page 17 and 18:
16 this measure has shown steady ga
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
24 HEDIS MEASURES of CARE about HEd
Page 27 and 28:
S A f E T y A N D P o T E N T I A l
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
W E l l N E S S A N D P R E V E N T
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
C H R o N I C D I S E A S E M A N A
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
M E A S U R E S T A R G E T E D A T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
C o N S U M E R A N D P A T I E N T
Page 123 and 124: C o N S U M E R A N D P A T I E N T
Page 129 and 130: 128 N AT I o N A l C o M M I T T E
Page 131 and 132: 130 APPENDIx 1: HEDIS EffECTIVENESS
Page 135 and 136: 134 APPENDIx 2: HEDIS EffECTIVENESS
Page 143 and 144: 142 APPENDIx 4b: ACCREDITED VS. NoN
Page 149 and 150: 148 APPENDIx 6A: ACCREDITED VS. NoN
Page 151 and 152: 150 APPENDIx 6b: ACCREDITED VS. NoN
Page 153 and 154: 152 APPENDIx 7A: PUblICly REPoRTING
Page 159 and 160: 158 APPENDIx 8: PUblICly REPoRTING
Page 173: 172 MEASURE N AT I o N A l C o M M
Page 177 and 178: 176 MEASURE N AT I o N A l C o M M
Page 179 and 180: 178 MEASURE N AT I o N A l C o M M
Page 181 and 182: 180 APPENDIx 16A: VARIATIoN IN PlAN
Page 183 and 184: 182 APPENDIx 16b: VARIATIoN IN PlAN
Page 185 and 186: 184 REfERENCES N AT I o N A l C o M
Page 200 and 201: ACkNoWlEDGMENTS Health Plans The 20
show all

Continuous Improvement and the Expansion of Quality ... - NCQA

Create successful ePaper yourself

Delete template?

Save as template?